Latest Catechol-O-methyl transferase Stories
Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON,
For the first time, researchers have identified genetic differences between placebo responders and non-responders.
Do you like to do good things for other people?
New research shows a gene variant may help protect the memory and thinking skills of older people. The research will be published in the April 20, 2010, issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
The 1994 genocide in Rwanda resulted in the mass killing of up to one million people over the course of about 100 days.
LONDON, Dec. 9 /PRNewswire/ -- The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union (EU), which includes total sales of carbidopa/levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors and anticholinergics used for disease symptom relief.
Placebos are a sham â€” usually mere sugar pills designed to represent "no treatment" in a clinical treatment study. The effectiveness of the actual medication is compared with the placebo to determine if the medication works.
- A transitional zone between two communities containing the characteristic species of each.